Harbor is an AI-native contract research organization (CRO) for clinical trial operations. It began as an AI-enabled electronic data capture system and has expanded into full-service trial execution, automating workflows such as study design, data capture, query generation, monitoring, and database management. By building on its proprietary system of record, Harbor delivers the regulated services companies traditionally buy from legacy CROs while reducing manual labor and accelerating timelines. The company was founded by Albert Cai (CEO), previously in clinical trials and regulatory strategy at Biolinq, and Nathan H. Leung (CTO), a former Google and Ramp engineer; it is part of Y Combinator's Spring 2026 batch.
Harbor
ActiveAI-native CRO for clinical trial operations
Total raised
$500K
1 round
Stage
Seed
Jan 2026
Team
1-10
since 2026
Pricing
—
Founded
2026
United States
Agent-ready
—
AI-native contract research organization for clinical trials
Proprietary electronic data capture system as a system of record
Automated study design workflows
Automated data capture and query generation
Automated trial monitoring
Database management for clinical studies
Full-service trial execution built on its own platform
Reduces manual labor across regulated trial operations
12/100
Early
MCP server
Public API
Webhooks
OAuth 2.0
SDKs
No public agent surfaces detected yet.
Jan 2026 Seed $500K ● Y Combinator
Capital network
$500K raised ·1 backer·10 network links
- Backers1
- Shared portfoliocompanies these backers also fund
- Extended networkfunds that co-invest alongside them
Pearl Health
AI value-based care platform for primary care providers
AI AnalyticsAI Healthcare
Commure
AI Healthcare
Innovaccer
AI Healthcare
Truveta
AI Healthcare
Terray Therapeutics
Generative AI and ultra-high-throughput chemistry for small-molecule drug discovery
AI HealthcareDrug Discovery
Genesis Molecular AI
Generative AI for small-molecule drug discovery
AI HealthcareDrug Discovery
- What is Harbor?
- Harbor is an AI-native contract research organization (CRO) for clinical trial operations, automating workflows from study design through database management.
- How did Harbor start?
- It began as an AI-enabled electronic data capture system and expanded into full-service trial execution built on its proprietary system of record.
- What does it automate?
- It automates study design, data capture, query generation, monitoring, and database management.
- Who founded Harbor?
- It was founded by Albert Cai (CEO), who previously worked in clinical trials and regulatory strategy. Harbor is part of Y Combinator's Spring 2026 batch.
Discussion
Sign in to join the discussion.
Sign inExplore more around Harbor
Contextual paths to related AI startups, deals and rankings.